Predictors of short-term clinical response to cardiac resynchronization therapy. 2017

Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.

Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in patients with symptomatic heart failure and QRS prolongation but there is uncertainty about which patient characteristics predict short-term clinical response. In an individual patient meta-analysis of three double-blind, randomized trials, clinical composite score (CCS) at 6 months was compared in patients assigned to CRT programmed on or off. Treatment-covariate interactions were assessed to measure likelihood of improved CCS at 6 months. MIRACLE, MIRACLE ICD, and REVERSE trials contributed data for this analysis (n = 1591). Multivariable modelling identified QRS duration and left ventricular ejection fraction (LVEF) as predictors of CRT clinical response (P < 0.05). The odds ratio for a better CCS at 6 months increased by 3.7% for every 1% decrease in LVEF for patients assigned to CRT-on compared to CRT-off, and was greatest when QRS duration was between 160 and 180 ms. In symptomatic chronic heart failure patients (NYHA class II-IV), longer QRS duration and lower LVEF independently predict early clinical response to CRT.

UI MeSH Term Description Entries
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016277 Ventricular Function, Left The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance. Left Ventricular Function,Function, Left Ventricular,Functions, Left Ventricular,Left Ventricular Functions,Ventricular Functions, Left
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017147 Defibrillators, Implantable Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes. Cardioverter-Defibrillators, Implantable,Implantable Cardioverter Defibrillator,Implantable Cardioverter-Defibrillators,Implantable Defibrillators,Cardioverter Defibrillator, Implantable,Cardioverter Defibrillators, Implantable,Cardioverter-Defibrillator, Implantable,Defibrillator, Implantable,Defibrillator, Implantable Cardioverter,Defibrillators, Implantable Cardioverter,Implantable Cardioverter Defibrillators,Implantable Cardioverter-Defibrillator,Implantable Defibrillator
D058406 Cardiac Resynchronization Therapy The restoration of the sequential order of contraction and relaxation of the HEART ATRIA and HEART VENTRICLES by atrio-biventricular pacing. Atrio-Biventricular Pacing,Biventricular Pacing,Cardiac Resynchronization,Cardiac Resynchronization Pacing Therapy,Resynchronization Pacing Therapy, Cardiac,Atrio Biventricular Pacing,Pacing, Atrio-Biventricular,Pacing, Biventricular,Resynchronization Therapy, Cardiac,Resynchronization, Cardiac,Therapy, Cardiac Resynchronization

Related Publications

Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
April 2013, Journal of cardiovascular medicine (Hagerstown, Md.),
Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
April 2014, BMC cardiovascular disorders,
Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
January 2024, Journal of cardiovascular electrophysiology,
Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
December 2013, Journal of cardiovascular medicine (Hagerstown, Md.),
Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
December 2016, International journal of cardiology,
Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
April 2005, American heart journal,
Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
January 2019, Indian heart journal,
Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
February 2018, Open access Macedonian journal of medical sciences,
Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
June 2014, Journal of cardiac failure,
Cecilia Linde, and William T Abraham, and Michael R Gold, and J Claude Daubert, and Anthony S L Tang, and James B Young, and Lou Sherfesee, and J Harrison Hudnall, and Dedra H Fagan, and John G Cleland
May 2011, Chinese medical journal,
Copied contents to your clipboard!